2019 GOLD COPD International Conference

2019 GOLD COPD International Conference is organized by Temple Lung Center and will be held on Nov 05, 2019 at Hilton Philadelphia City Avenue, Philadelphia, Pennsylvania, United States of America.

Target Audience: 
This activity addresses the needs of physicians, physician assistants, respiratory therapists, nurse practitioners, nurses, cases managers, cardiopulmonary specialists, and other healthcare professionals involved in the diagnosis and treatment of patients with COPD.

Accreditation:
Physician Credit Designation:
Integrity CE designates this live activity for a maximum of 8.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education:
This educational activity for 8.5 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioner Continuing Education:
This activity is approved for 8.5 contact hour(s). Pharmacology hours to be determined upon clinical review.

Pharmacist Accreditation Statement:
Global Education Group designates this continuing education activity for 8.5 contact hour(s) (0.85 CEUs) of the Accreditation Council for Pharmacy Education.

Respiratory Care Continuing Education:
Application has been made to the American Association for Respiratory Care (AARC) for 8.5 continuing respiratory care education (CRCE) contact hours for respiratory therapists.

Learning Objectives:
Upon completion of this educational activity, participants will be able to:
• Review the most recent GOLD guidelines for the management of patients with COPD
• Utilize guideline recommendations for the management of patients with COPD in all courses of disease
• Describe treatable traits in COPD
• Discuss the role of endotypes, phenotypes, and biomarkers in the management of COPD
• Utilize endotypes, phenotypes, and biomarkers to aid in personalized decision making in COPD
• Review the rationale and principles for the management of hypercapnia
• Discuss the overlap between COPD and sleep disorders and recommendations for management
• Review common comorbidities of COPD and their impact on patient management
• Identify strategies for the management and reduction of exacerbations in patients with COPD
• Discuss the role of various therapies in the management of COPD exacerbations including bronchodilators, corticosteroids, oral steroids, and antibiotics
• Identify chronic bronchitis in patients who have frequent COPD exacerbations and mitigate effects of the comorbidity
• Describe hyperinflation and principles of diagnosis
• Differentiate available therapies for treatment of hyperinflation including bronchodilators, oxygen, ventilation, and surgical and interventional treatments

Additional details will be posted as soon as information is available.